Latest Breaking News On - First interventional phase - Page 1 : comparemela.com

WATERTOWN, Mass., March 13, 2024 Vigil Neuroscience, Inc. , a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative diseases,.

United statesDavids lynchMegan mcgrathZbigniew wszolekLeah gibsonAbbie renouxVigil neuroscience incInvestor relations corporate communicationsUniversity college london institute of neurologyAmerican academy of neurologyNational hospital for neurology neurosurgeryAnnual meetingInterim resultsFirst interventional phaseAdult onset leukoencephalopathyAxonal spheroids